![Gerald Pier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Gerald B. Pier is the founder of Alopexx, Inc., founded in 2006, holding the title of Chief Scientific Advisor.
Dr. Pier is also the founder of Alopexx Enterprises LLC..
Dr. Pier currently holds the position of Professor at Harvard Medical School.
Dr. Pier earned a doctorate from the University of California, Berkeley and completed undergraduate studies at the University of the Pacific.
Actieve functies van Gerald Pier
| Bedrijven | Functie | Begin |
|---|---|---|
| ALOPEXX, INC. | Oprichter | 01-01-2006 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Alopexx Enterprises LLC
 Alopexx Enterprises LLC BiotechnologyHealth Technology Engages in investing and managing health care companies | Oprichter | - |
Opleiding van Gerald Pier
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
88
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Pacific
 University of the Pacific Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alopexx Enterprises LLC
Alopexx Enterprises LLC BiotechnologyHealth Technology Engages in investing and managing health care companies | Health Technology |
Alopexx, Inc.
 Alopexx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops novel and broad-spectrum immune-mediated therapeutics | Health Technology |
